CHM.CN Stock Surges 900% in May 2026 Trading Session

Waverunner Capital Inc. (CHM.CN) delivered a stunning 900% surge on May 8, 2026, climbing to C$0.05 per share on the CNQ exchange. The venture capital firm, based in North Vancouver, experienced extreme volatility as traders reacted to the stock’s dramatic price movement. CHM.CN stock has captured attention for its explosive intraday action, though investors should note the company’s challenging financial metrics. The stock trades with significant risk, reflecting Waverunner’s early-stage investment focus across renewable energy, biotechnology, and consumer sectors.

CHM.CN Stock Price Action and Market Movement

CHM.CN stock exploded higher today, jumping from a previous close of C$0.005 to C$0.05, marking a 900% gain in a single session. The stock’s day range remained flat at C$0.05, suggesting the move occurred early in trading before stabilizing. Over the past five days, CHM.CN stock has climbed 400%, while the one-year performance shows similar gains of 400%. However, the longer-term picture tells a different story. The stock trades well below its 52-week high of C$0.10, and has declined 80.4% over five years and 93.3% over a decade, indicating severe long-term erosion in shareholder value.

Trading Volume and Liquidity Concerns

Average daily volume sits at just 28,908 shares, which is extremely thin for a public company. This low liquidity means large trades can move the price dramatically, explaining today’s volatile action. The market cap of C$37.2 million reflects Waverunner’s modest size in the venture capital space. With 744.2 million shares outstanding, the per-share metrics are heavily diluted, making percentage gains less meaningful than they appear. Investors should be cautious about trading in such illiquid securities, as entry and exit prices can vary significantly.

Waverunner Capital Inc. Business Model and Investment Strategy

Waverunner Capital Inc., formerly known as Chemistree Technology Inc. until June 2024, operates as a venture capital firm specializing in early-stage and seed-stage investments. The company focuses on PIPEs (private investments in public equity), bridge financing, recapitalizations, and secondary limited partner interests. CEO Karl Eric Kottmeier leads the firm from its North Vancouver headquarters at 828 Harbourside Drive. Waverunner targets equity investments between C$500,000 and C$1 million, with enterprise values between C$2 million and C$5 million.

Investment Focus Areas

The firm maintains a diversified portfolio spanning renewable energy (wind and solar), plant-based wellness, consumer-targeted biotechnology, and resources sectors. Waverunner invests across Europe and North America, using both its own balance sheet and personal capital. This venture capital model exposes shareholders to significant risk, as early-stage companies often fail. The company’s classified sector as Healthcare reflects its biotechnology holdings, though the business model is fundamentally different from traditional drug manufacturers. Track CHM.CN on Meyka for real-time updates on this venture capital investment vehicle.

Financial Health and Key Metrics Analysis

CHM.CN stock’s financial metrics reveal significant operational challenges. The company reported a negative EPS of -C$0.01 and a negative PE ratio of -5.0, indicating ongoing losses. Net income per share stands at -C$0.0595, while operating cash flow per share is -C$0.0045. The current ratio of 0.097 is dangerously low, suggesting potential liquidity problems and difficulty meeting short-term obligations. Book value per share is -C$0.1422, meaning shareholders’ equity is negative.

Profitability and Solvency Concerns

Waverunner’s debt-to-assets ratio of 1.41 indicates liabilities exceed assets, a red flag for financial stability. The company carries C$0.092 in interest debt per share, creating ongoing obligations despite losses. Return on assets is -0.94%, and return on equity is 0.47%, both weak indicators. The company generated zero revenue per share, meaning Waverunner is not generating income from operations. These metrics suggest the firm is burning capital while waiting for portfolio companies to mature or exit. Investors should understand this is a speculative venture capital play, not a profitable operating business.

Market Sentiment and Trading Activity

The 900% surge in CHM.CN stock reflects extreme market sentiment swings typical of micro-cap, illiquid securities. Such dramatic moves often occur on minimal volume and can reverse just as quickly. The stock’s 50-day moving average of C$0.0424 and 200-day moving average of C$0.0481 both sit above today’s price, suggesting the stock has been trading in a narrow range before this spike. Meyka AI rates CHM.CN with a grade of B, with a score of 61.4 out of 100. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are not guaranteed and we are not financial advisors.

Liquidation and Risk Factors

The thin trading volume means any significant selling pressure could trigger sharp declines. Venture capital firms like Waverunner face inherent risks: portfolio company failures, market downturns affecting exit opportunities, and capital depletion. The company’s negative working capital of -C$520,504 indicates operational stress. With no analyst coverage or price target consensus available, investors lack institutional guidance. The stock’s extreme volatility makes it unsuitable for conservative portfolios and should only be considered by risk-tolerant traders with speculative capital.

Final Thoughts

CHM.CN’s 900% surge on May 8, 2026, reflects extreme volatility in a micro-cap venture capital stock, not fundamental strength. Waverunner Capital Inc. faces negative earnings, weak equity, poor liquidity, and minimal trading volume. The stock has fallen 80% over five years. This highly speculative investment suits only experienced traders with disposable capital. The dramatic price jump stems from illiquidity rather than business improvement.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.